Commercial Services

E-detailing, Hybrid and Virtual Pharmaceutical Sales Solutions

At Diligent, our Inside and Hybrid (combination of Inside and Field-based) Sales solutions are driven by our clients’ business goals. Before we do anything else, we listen and ask insightful questions. Once we have a complete understanding of what needs to be accomplished, we leverage our decades of experience to provide a customized strategic plan.

Our long heritage in providing e-detailing, hybrid and virtual pharmaceutical sales solutions has fine-tuned our ability to assign every program a team best suited to meet its objectives. Our programs are staffed by sales representatives with the right profile for the specific business need—including varying levels of demand due to seasonality, changes in office access, vacant territories, and field-based staffing fluctuations.

Diligent’s sales representatives include pharmacists, pharma sales reps with field experience, and inside sales professionals. Our decades of experience and our utilization of behavior-based panel interviews allow us to confidently hire Representatives who are well-suited to their assigned role—in temperament as well as background.

While we respect that some sales programs are by necessity script-driven, we are adept at recruiting representatives who—after training provided by our client or by Diligent—can speak to HCPs conversationally about a specific disease state and/or therapy based on the client- provided training and resource materials.

Our Salesforce platform allows for the collection of data not typically captured in field-based sales CRMs (for example: call time spent on a specific call element) resulting in enhanced reporting capabilities.

Our Pharmaceutical Inside Sales (Virtual Pharmaceutical Sales) & Hybrid Sales Solutions are tailored to the goals of our life science partners and include:

  • Detailing. Providing HCPs with scientific information about a specific drug, including its benefits and potential side effects.
  • E-detailing. Providing digitized scientific content to HCPs.
  • Drug Sampling. Offering drug samples to licensed practitioners, in accordance with client processes and federal regulations.
  • Profiling. Pre-launch identification and analysis of key prescriber targets.
  • HCP Education & Awareness. Providing educational messages on new drugs approved by the FDA or drugs that have received an expanded approval.
  • Formulary Changes. Notifying HCPs on major formulary changes for generic and brand-name drugs.
  • Rx-to-OTC Switch. Notifying HCPs of drugs in the process of transferring from prescription to non-prescription status.

Additional Commercial Services